	Ebit		Date
AbbVie	USD 5.81B	4.36B	2025-12
Acadia Pharmaceuticals	USD 17.39M	18.36M	2025-12
Akebia Therapeutics	USD 13.51M	27.82M	2025-03
ALKERMES	USD -10.95M	100.03M	2025-12
Alnylam Pharmaceuticals	USD 29.4M	59.36M	2025-12
Amarin	USD -1.7M	8.47M	2025-09
Amgen	USD 3.96B	464M	2025-12
Baxter International	USD -214.2M	415.4M	2025-12
Biogen	USD 659.6M	157M	2025-09
BioMarin Pharmaceutical	USD 198.39M	230.08M	2025-12
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Coherus Biosciences	USD -45.43M	3.19M	2025-03
Eli Lilly	USD 8.99B	1.57B	2025-12
Fujifilm	JPY 89.96B	6.77B	2025-12
Gilead Sciences	USD 2.96B	551M	2025-12
Ironwood Pharmaceuticals	USD 33.22M	7.58M	2024-12
Merck	USD 6.24B	1.32B	2025-12
Myriad Genetics	USD -5.5M	11.1M	2025-03
Pacira	USD 3.19M	9.96M	2025-12
Perrigo	USD 84.4M	9M	2025-12
Pfizer	USD 4.65B	71M	2025-12
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Regeneron Pharmaceuticals	USD 898.6M	211.3M	2025-12
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Teva Pharmaceutical Industries	USD 577M	491M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12
Xencor	USD -53.63M	6.11M	2025-12
Zoetis	USD 835M	140M	2025-12

Coherus Biosciences - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.